Literature DB >> 26392069

Liver transplantation: The effect of new HCV drugs on liver transplantation outcomes.

Didier Samuel1, Jean-Charles Duclos-Vallée1.   

Abstract

Liver transplantations for patients who are co-infected with HIV and HCV have always posed a challenge and still do, according to the results of a new study. This article discusses the factors that contribute to an increased risk of poor transplantation outcomes and how new treatment options might affect patient survival.

Entities:  

Mesh：

Year:  2015        PMID： 26392069     DOI： 10.1038/nrgastro.2015.165

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


  10 in total

Review 1.  Are HIV-infected patients candidates for liver transplantation?

Authors:  Didier Samuel; Rainer Weber; Peter Stock; Jean-Charles Duclos-Vallée; Norah Terrault
Journal:  J Hepatol       Date:  2008-02-27       Impact factor: 25.083

2.  Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience.

Authors:  Audrey Coilly; Bruno Roche; Jérôme Dumortier; Vincent Leroy; Danielle Botta-Fridlund; Sylvie Radenne; Georges-Philippe Pageaux; Si-Nafaa Si-Ahmed; Olivier Guillaud; Teresa Maria Antonini; Stéphanie Haïm-Boukobza; Anne-Marie Roque-Afonso; Didier Samuel; Jean-Charles Duclos-Vallée
Journal:  J Hepatol       Date:  2013-08-29       Impact factor: 25.083

3.  Liver transplantation in the human immunodeficiency virus-hepatitis C virus coinfected patient: time to sum up.

Authors:  Didier Samuel; Jean-Charles Duclos-Vallee
Journal:  Hepatology       Date:  2013-01       Impact factor: 17.425

4.  Outcome of HCV/HIV-coinfected liver transplant recipients: a prospective and multicenter cohort study.

Authors:  J M Miro; M Montejo; L Castells; A Rafecas; S Moreno; F Agüero; M Abradelo; P Miralles; J Torre-Cisneros; J D Pedreira; E Cordero; G de la Rosa; B Moyano; A Moreno; I Perez; A Rimola
Journal:  Am J Transplant       Date:  2012-04-04       Impact factor: 8.086

5.  Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: a prospective cohort study.

Authors:  Lluis Castells; Antoni Rimola; Christian Manzardo; Andrés Valdivieso; José Luis Montero; Rafael Barcena; Manuel Abradelo; Xavier Xiol; Victoria Aguilera; Magdalena Salcedo; Manuel Rodriguez; Carmen Bernal; Francisco Suarez; Antonio Antela; Sergio Olivares; Santos Del Campo; Montserrat Laguno; José R Fernandez; Gloria de la Rosa; Fernando Agüero; Iñaki Perez; Juan González-García; Juan I Esteban-Mur; Jose M Miro
Journal:  J Hepatol       Date:  2014-08-13       Impact factor: 25.083

6.  Fibrosing cholestatic hepatitis in HIV/HCV co-infected transplant patients-usefulness of early markers after liver transplantation.

Authors:  T M Antonini; M Sebagh; A M Roque-Afonso; E Teicher; B Roche; R Sobesky; A Coilly; P Vaghefi; R Adam; D Vittecoq; D Castaing; D Samuel; J-C Duclos-Vallée
Journal:  Am J Transplant       Date:  2011-07-12       Impact factor: 8.086

7.  Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.

Authors:  Michael Charlton; Gregory T Everson; Steven L Flamm; Princy Kumar; Charles Landis; Robert S Brown; Michael W Fried; Norah A Terrault; Jacqueline G O'Leary; Hugo E Vargas; Alexander Kuo; Eugene Schiff; Mark S Sulkowski; Richard Gilroy; Kymberly D Watt; Kimberly Brown; Paul Kwo; Surakit Pungpapong; Kevin M Korenblat; Andrew J Muir; Lewis Teperman; Robert J Fontana; Jill Denning; Sarah Arterburn; Hadas Dvory-Sobol; Theo Brandt-Sarif; Phillip S Pang; John G McHutchison; K Rajender Reddy; Nezam Afdhal
Journal:  Gastroenterology       Date:  2015-05-15       Impact factor: 22.682

8.  Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States.

Authors:  Deirdre Sawinski; David S Goldberg; Emily Blumberg; Peter L Abt; Roy D Bloom; Kimberly A Forde
Journal:  Clin Infect Dis       Date:  2015-06-16       Impact factor: 9.079

9.  Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus.

Authors:  Jean-Charles Duclos-Vallée; Cyrille Féray; Mylène Sebagh; Elina Teicher; Anne-Marie Roque-Afonso; Bruno Roche; Daniel Azoulay; René Adam; Henri Bismuth; Denis Castaing; Daniel Vittecoq; Didier Samuel
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

10.  Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity.

Authors:  Mariagrazia Tateo; Anne-Marie Roque-Afonso; Teresa Maria Antonini; Fadia Medja; Anne Lombes; Claude Jardel; Elina Teicher; Mylène Sebagh; Bruno Roche; Denis Castaing; Didier Samuel; Jean-Charles Duclos-Vallee
Journal:  AIDS       Date:  2009-06-01       Impact factor: 4.177
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.